Megan M Geloneck1, Brian J Forbes2, James Shaffer3, Gui-shuang Ying3, Gil Binenbaum4. 1. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 2. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 3. Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 4. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: binenbaum@email.chop.edu.
Abstract
PURPOSE: The effectiveness of annual eye examinations in diabetic children is unclear. We sought to determine the prevalence and onset of ocular pathology in children with diabetes mellitus (DM), identify risk factors for ocular disease, and recommend a screening regimen for asymptomatic children. DESIGN: Retrospective, consecutive cohort study. PARTICIPANTS: Children aged less than 18 years with type 1 or 2 DM examined over a 4-year period. METHODS: All children underwent a complete eye examination, including dilated fundoscopy and cycloplegic refraction. A literature review was performed, identifying the youngest reported age and shortest reported duration of DM before the diagnosis of diabetic retinopathy (DR). MAIN OUTCOME MEASURES: Prevalence of DR, cataract, high refractive error, and strabismus. RESULTS: A total of 370 children (mean age, 11.2 years; range, 1-17.5 years) had 693 examinations, with a mean DM duration of 5.2 years (range, 0.1-16.2 years) and a mean hemoglobin A1c (HbA1c) of 8.6 (range, 5-≥14). No children had DR. A total of 12 children had cataract; 5 required extraction but were identified by decreased vision, not diabetic screening. A total of 19 children had strabismus; only 1 was microvascular paralytic strabismus. A total of 41 children had high refractive error. There were no associations between these conditions and duration or control of DM. In the literature, the youngest age at diagnosis of severe DR was 15 years, and the shortest duration of disease was 5 years. CONCLUSIONS: Diabetic retinopathy is rare in children regardless of duration and control of DM. On the basis of our study and literature review, screening examinations for type 1 diabetes could begin at age 15 years or at 5 years after the diagnosis of DM, whichever occurs later, unless the child is judged by the endocrinologist as being at unusually high risk. Other ocular complications are identifiable through existing amblyopia screening methods.
PURPOSE: The effectiveness of annual eye examinations in diabeticchildren is unclear. We sought to determine the prevalence and onset of ocular pathology in children with diabetes mellitus (DM), identify risk factors for ocular disease, and recommend a screening regimen for asymptomatic children. DESIGN: Retrospective, consecutive cohort study. PARTICIPANTS: Children aged less than 18 years with type 1 or 2 DM examined over a 4-year period. METHODS: All children underwent a complete eye examination, including dilated fundoscopy and cycloplegic refraction. A literature review was performed, identifying the youngest reported age and shortest reported duration of DM before the diagnosis of diabetic retinopathy (DR). MAIN OUTCOME MEASURES: Prevalence of DR, cataract, high refractive error, and strabismus. RESULTS: A total of 370 children (mean age, 11.2 years; range, 1-17.5 years) had 693 examinations, with a mean DM duration of 5.2 years (range, 0.1-16.2 years) and a mean hemoglobin A1c (HbA1c) of 8.6 (range, 5-≥14). No children had DR. A total of 12 children had cataract; 5 required extraction but were identified by decreased vision, not diabetic screening. A total of 19 children had strabismus; only 1 was microvascular paralytic strabismus. A total of 41 children had high refractive error. There were no associations between these conditions and duration or control of DM. In the literature, the youngest age at diagnosis of severe DR was 15 years, and the shortest duration of disease was 5 years. CONCLUSIONS:Diabetic retinopathy is rare in children regardless of duration and control of DM. On the basis of our study and literature review, screening examinations for type 1 diabetes could begin at age 15 years or at 5 years after the diagnosis of DM, whichever occurs later, unless the child is judged by the endocrinologist as being at unusually high risk. Other ocular complications are identifiable through existing amblyopia screening methods.
Authors: P Palmberg; M Smith; S Waltman; T Krupin; P Singer; D Burgess; T Wendtlant; J Achtenberg; P Cryer; J Santiago; N White; C Kilo; W Daughaday Journal: Ophthalmology Date: 1981-07 Impact factor: 12.079
Authors: Marianne Henricsson; Lennarth Nyström; Göran Blohmé; Jan Ostman; Carin Kullberg; Maria Svensson; Anna Schölin; Hans J Arnqvist; Elisabeth Björk; Jan Bolinder; Jan W Eriksson; Göran Sundkvist Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: Julia M Hermann; Hans-Peter Hammes; Birgit Rami-Merhar; Joachim Rosenbauer; Morten Schütt; Erhard Siegel; Reinhard W Holl Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240
Authors: Rose A Gubitosi-Klug; Ionut Bebu; Neil H White; John Malone; Ryan Miller; Gayle M Lorenzi; Dean P Hainsworth; Victoria R Trapani; John M Lachin; William V Tamborlane Journal: Pediatr Diabetes Date: 2019-07-09 Impact factor: 4.866
Authors: Sophia Y Wang; Chris A Andrews; William H Herman; Thomas W Gardner; Joshua D Stein Journal: Ophthalmology Date: 2016-11-30 Impact factor: 12.079
Authors: Chelsea Zimmerman; Brittany Bruggeman; Amanda LaPorte; Shalesh Kaushal; Michael Stalvey; Giovanna Beauchamp; Kristin Dayton; Paul Hiers; Stephanie L Filipp; Matthew J Gurka; Janet H Silverstein; Laura M Jacobsen Journal: Diabetes Spectr Date: 2021-01
Authors: James Rafferty; David R Owens; Stephen D Luzio; Patrick Watts; Ashley Akbari; Rebecca L Thomas Journal: Eye (Lond) Date: 2020-12-01 Impact factor: 4.456
Authors: P Ruiz-Ocaña; P Espinoza Requena; A Alonso-Ojembarrena; P Alemany Márquez; S Jiménez Carmona; A M Lechuga-Sancho Journal: Int J Endocrinol Date: 2018-04-26 Impact factor: 3.257
Authors: Marko Šimunović; Martina Paradžik; Roko Škrabić; Ivana Unić; Kajo Bućan; Veselin Škrabić Journal: Int J Endocrinol Date: 2018-03-20 Impact factor: 3.257